These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9550242)

  • 1. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
    Spreat S; Conroy J
    Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of psychotropic medication in Oklahoma: a statewide survey.
    Spreat S; Conroy JW; Jones JC
    Am J Ment Retard; 1997 Jul; 102(1):80-5. PubMed ID: 9241410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental illness and psychotropic medication use in the nursing home.
    Arling G; Ryther BJ; Collins T; Zimmerman D
    J Aging Health; 1991 Nov; 3(4):455-72. PubMed ID: 10115034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries.
    Snowdon J; Galanos D; Vaswani D
    Int Psychogeriatr; 2011 Nov; 23(9):1520-5. PubMed ID: 21429281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statewide longitudinal survey of psychotropic medication use for persons with mental retardation: 1994 to 2000.
    Spreat S; Conroy JW; Fullerton A
    Am J Ment Retard; 2004 Jul; 109(4):322-31. PubMed ID: 15176915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
    Keast SL; Tidmore LM; Shropshire D; Nesser N; Lambert TL
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1340-1348. PubMed ID: 31778625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic drug prescriptions for nursing home residents.
    Burns BJ; Kamerow DB
    J Fam Pract; 1988 Feb; 26(2):155-60. PubMed ID: 3339319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.
    Maust DT; Oslin DW; Marcus SC
    J Am Geriatr Soc; 2014 Feb; 62(2):358-64. PubMed ID: 24417590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
    Gobert M; D'hoore W
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study on the use of psychotropic medication in persons with mental retardation.
    Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.